Infertility and pregnancy after breast cancer: Current knowledge and future perspectives

被引:38
作者
Del Mastro, Lucia
Catzeddu, Tiziana
Venturini, Marco
机构
[1] Natl Inst Canc Res, Dept Med Oncol, I-16132 Genoa, Italy
[2] Osped Sacro Cuore Don Calabria, Dept Med Oncol, I-37024 Verona, Italy
关键词
adjuvant therapy; amenorrhea; breast cancer; infertility; latrogenic menopause; pregnancy;
D O I
10.1016/j.ctrv.2006.05.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Fertility impairment induced by adjuvant treatments and potential risk associated with pregnancy, are major concerns of young pre-menopausal patients with early breast cancer. Although current evidences suggest that pregnancy does not negatively affect prognosis, a low rate (3-8%) of pregnancy after breast cancer has been reported. Among the potentiat causes of such a low rate there are a high chance of spontaneous abortions (25%) as well. as the fertility impairment induced by adjuvant treatments. No standard strategy to preserve fertility in breast cancer patients is available so far. Experimental approaches include cryopreservation strategies, and use of gonadotropin-releasing hormone (GnRH) agonists to render germinal epithelium quiescent and less sensitive to the chemotherapy cytotoxicity. Here, we reviewed current knowledge about incidence and risks of pregnancy after breast cancer, risks of ovarian failure after adjuvant treatments and experimental strategies aiming to preserve ovarian function and fertility in young breast cancer patients. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:417 / 422
页数:6
相关论文
共 47 条
[21]   Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer [J].
Henderson, IC ;
Berry, DA ;
Demetri, GD ;
Cirrincione, CT ;
Goldstein, LJ ;
Martino, S ;
Ingle, JN ;
Cooper, MR ;
Hayes, DF ;
Tkaczuk, KH ;
Fleming, G ;
Holland, JF ;
Duggan, DB ;
Carpenter, JT ;
Frei, E ;
Schilsky, RL ;
Wood, WC ;
Muss, HB ;
Norton, L .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (06) :976-983
[22]   Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study [J].
Jonat, W ;
Kaufmann, M ;
Sauerbrei, W ;
Blamey, R ;
Cuzick, J ;
Namer, M ;
Fogelman, I ;
de Haes, JC ;
de Matteis, A ;
Stewart, A ;
Eiermann, W ;
Szakolczai, I ;
Palmer, M ;
Schumacher, M ;
Geberth, M ;
Lisboa, B .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (24) :4628-4635
[23]   Should women be advised against pregnancy after breast-cancer treatment? [J].
Kroman, N ;
Jensen, MB ;
Melbye, M ;
Wohlfahrt, J ;
Mouridsen, HT .
LANCET, 1997, 350 (9074) :319-322
[24]   Factors influencing the effect of age on prognosis in breast cancer: population based study [J].
Kroman, N ;
Jensen, MB ;
Wohlfahrt, J ;
Mouridsen, HT ;
Andersen, PK ;
Melbye, M .
BRITISH MEDICAL JOURNAL, 2000, 320 (7233) :474-478
[25]   Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer [J].
Levine, MN ;
Bramwell, VH ;
Pritchard, KI ;
Norris, BD ;
Shepherd, LE ;
Abu-Zahra, H ;
Findlay, B ;
Warr, D ;
Bowman, D ;
Myles, J ;
Arnold, A ;
Vandenberg, T ;
MacKenzie, R ;
Robert, J ;
Ottaway, J ;
Burnell, M ;
Williams, CK ;
Tu, DS .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2651-2658
[26]   Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998 [J].
Li, CI ;
Daling, JR ;
Malone, KE .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (01) :28-34
[27]   Current concepts - Potential options for preservation of fertility in women [J].
Lobo, RA .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (01) :64-73
[28]  
Malamos NA, 1996, ONCOLOGY, V53, P471
[29]   Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: Results from NSABP B-28 [J].
Mamounas, EP ;
Bryant, J ;
Leinbersky, B ;
Fehrenbacher, L ;
Sedlacek, SM ;
Fisher, B ;
Wickerham, DL ;
Yothers, G ;
Soran, A ;
Wolmark, N .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :3686-3696
[30]   Adjuvant docetaxel for node-positive breast cancer [J].
Martin, M ;
Pienkowski, T ;
Mackey, J ;
Pawlicki, M ;
Guastalla, JP ;
Weaver, C ;
Tomiak, E ;
Al-Tweigeri, T ;
Chap, L ;
Juhos, E ;
Guevin, R ;
Howell, A ;
Fornander, T ;
Hainsworth, J ;
Coleman, R ;
Vinholes, J ;
Modiano, M ;
Pinter, T ;
Tang, SC ;
Colwell, B ;
Prady, C ;
Provencher, L ;
Walde, D ;
Rodriguez-Lescure, A ;
Hugh, J ;
Loret, C ;
Rupin, M ;
Blitz, S ;
Jacobs, P ;
Murawsky, M ;
Riva, A ;
Vogel, C .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (22) :2302-2313